These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 5820416

  • 1. The prophylactic action of polyvinylpyridine N-oxide (P 204) in silicosis. An experimental study.
    Pott F, Schlipköter HW, Brockhaus A.
    Ger Med Mon; 1969 Jul; 14(7):337-40. PubMed ID: 5820416
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Animal experimental fundamentals in the medicinal prevention of silicosis using polyvinylpyridine-N-oxide (P204)].
    Pott F, Schlipköter HW, Brockhaus A.
    Dtsch Med Wochenschr; 1968 Dec 20; 93(51):2479-82. PubMed ID: 5724499
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. [Antisilicotic properties of polyvinylpyridine-N-oxide with a different molecular weight].
    Dubovik BV, Shadurskiĭ KS, Etlis VS, Lushnikova GA, Shevchuk AS.
    Farmakol Toksikol; 1971 Dec 20; 34(3):352-7. PubMed ID: 5568700
    [No Abstract] [Full Text] [Related]

  • 13. [Antisilicosis activity of PVPO administered intratracheally and by inhalation (an experimental study)].
    Rodkina BS, Bolonova LN.
    Gig Tr Prof Zabol; 1979 Sep 20; (9):32-6. PubMed ID: 535751
    [No Abstract] [Full Text] [Related]

  • 14. [Inhibition of experimental silicosis by subcutaneous administration of polyvinylpyridine-N-oxide].
    SCHLIPKOETER HW, BROCKHAUS A.
    Klin Wochenschr; 1961 Nov 15; 39():1182-9. PubMed ID: 14498575
    [No Abstract] [Full Text] [Related]

  • 15. [Possible paths for influencing the mechanism of experimental silicosis].
    Shnaĭdman IM, Raĭkhlin NT.
    Biull Eksp Biol Med; 1973 Jun 15; 75(6):27-30. PubMed ID: 4149770
    [No Abstract] [Full Text] [Related]

  • 16. [Cytopharmacologic effect of using polyvinylpyridine-N-oxide in experimental silicosis].
    Arutiunov VD, Kruglikov GG, Batsura IuD, Fedorova VI.
    Biull Eksp Biol Med; 1977 Mar 15; 83(3):371-4. PubMed ID: 856357
    [Abstract] [Full Text] [Related]

  • 17. [Preventive and curative silicotropic effect of polyvinylpyridine-N-oxide in liver and spleen tests].
    Hennies H, Eger K, Eger W.
    Beitr Silikoseforsch; 1967 Mar 15; 93():15-32. PubMed ID: 6072453
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Behavior of the human liver during silicosis therapy using polyvinylpyridine-N-oxide (PVNO)].
    Haas P, Huber W.
    Beitr Silikoseforsch Pneumokoniose; 1971 Mar 15; 23(3):91-100. PubMed ID: 5171411
    [No Abstract] [Full Text] [Related]

  • 20. The protective influence of polyvinylpyridine-N-oxide in experimental silicosis.
    Cavagna G, Nichelatti T.
    Med Lav; 1963 Oct 15; 54(10):621-7. PubMed ID: 5878631
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.